Ventriculoamniotic shunt for fetal aqueductal stenosis
a technology of fetal aqueductal stenosis and ventriculoamniotic shunt, which is applied in the direction of medical devices, medical devices, coatings, etc., can solve the problems of severe cns ventriculomegaly, damage to the developing brain, and associated neurologic consequences, so as to prevent the migration of the shunt device
Pending Publication Date: 2022-08-04
UNIV OF PITTSBURGH OF THE COMMONWEALTH SYST OF HIGHER EDUCATION
View PDF0 Cites 0 Cited by
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Benefits of technology
The patent text describes a way to prevent a shunt tube (a device used to treat hydrocephalus) from migrating in the patient's body. The method involves attaching a wire or mesh made of a material called shape memory alloy to the tube. This wire or mesh is designed to expand outward from the tube's surface and is connected to it using a mechanism. The technical effect of this is to create a barrier that prevents the tube from moving in the patient's body.
Problems solved by technology
In the early life hydrocephalus group, fetal hydrocephalus is of significant concern since children with an obvious prenatal onset of hydrocephalus have been found to be at high risk for early death or multiple neurological impairments.
Fetal pressure hydrocephalus, due to obstruction of flow of fluid through and then out of the ventricular system, damages the developing brain.
Neurologic consequences are devastating and permanent.
In general, severe CNS ventriculomegaly is associated with poor neurologic outcomes.
Increased intracranial pressure results in compression of the cortical mantle, decreased vascular perfusion, and subsequent tissue ischemia.
Additionally, expansion of the ventricular system causes distention of the brain tissue and mechanical axonal shear.
In-utero shunting of CSF from the ventricles to the amniotic fluid was attempted in the 1980s with the expectation of improving neurologic and pregnancy outcomes, but was abandoned due to a perceived lack of effect that was likely due to technological limitations at the time.
They had a tendency to clog and additionally, migrate since there was no effective means for anchoring the device to prevent dislodgement.
However, shunting was abandoned in the mid-1980s due to a perceived lack of effect.
In retrospect, the lack of effect was likely due to poor patient selection and technical difficulties as a consequence of technological limitations at the time.
Not surprisingly, analysis of the data on pregnancy outcomes after shunting showed no clear benefit.
A moratorium was placed on fetal ventriculoamniotic shunting in the mid-1980s and since, there has been almost no progress in treatment of fetal hydrocephalus and ventriculoamniotic shunts are not commercially available.
Also, there has been no significant progress made in the last few decades on the antenatal management of severe ventriculomegaly.
Prenatal ventricular decompression is currently not a management option for fetal pressure hydrocephalus.
Problems associated with early delivery are concomitant prematurity, poor surgical candidacy, and a greater rate of shunt complications.
Problems associated with expectant management are ongoing brain injury and obstetric complications related to macrocephaly (excessively large fetal head), which can impact the current as well as future pregnancies due to the need for cesarean delivery.
The type of cesarean section typically required is a “classical,” or vertical uterine incision which is subject to rupture in subsequent pregnancies, placing both mother and fetus at risk for death or disability.
This represents an unfavorable risk-benefit assessment as the mother is exposed to significant risk, but the newborn may not receive benefit since neurologic damage is typically complete by term.
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View moreExamples
Experimental program
Comparison scheme
Effect test
example
[0083]Fetal sheep were injected with BioGlue, a biological epoxy of purified bovine albumin and glutaraldehyde, into the cisterna magna at mid-gestation (80-90 days of 145 days gestation). The BioGlue remained within the cisterna magna and therefore, did not interfere with or obscure intraventricular histology. The shut device was placed at varying gestational ages between 110 and 130 days. Shunted brains were compared to non-shunted hydrocephalic controls at term. Using immunocytochemical staining, the hypothesis that neuronal injury in fetal hydrocephalus is secondary to increased intracranial pressure, which leads to tissue ischemia and mechanical axonal shear, was supported.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more PUM
Login to view more Abstract
The invention relates to an in-utero ventriculoamniotic shunting device that includes a composite shunt tube composed of polymer material, e.g., silicone-based material, and metallic wire, having a bend or curve formed in the length of the shunt tube, with one or more anchors composed of super-elastic wire or mesh, e.g., shape memory alloy wire or mesh structures, attached to the shunt tube, and a one-way passive valve composed of a thin polymer membrane. The anchors are effective to prevent migration and dislodgement of the shunting device following its deployment, and the valve is effective to prevent the backflow of amniotic fluid.
Description
CROSS-REFERENCE TO RELATED APPLICATION[0001]This application claims priority under 35 U.S.C. § 119(e) to U.S. Provisional Patent Application Ser. No. 62 / 853,778, filed on May 29, 2019, entitled “VENTRICULOAMNIOTIC SHUNT FOR FETAL AQUEDUCTAL STENOSIS”, which is herein incorporated by reference.FIELD OF THE INVENTION[0002]The invention relates to a ventriculoamniotic device, e.g., shunt, for in-utero implantation to treat fetal aqueductal stenosis.BACKGROUND[0003]Severe fetal central nervous system (CNS) ventriculomegaly is a relatively common prenatal diagnosis, and it is known that fetal pressure hydrocephalus causes damage to the developing brain of a fetus or newborn. Hydrocephalus is defined as a clinical entity in which a disturbance of cerebrospinal fluid (CSF) circulation causes the accumulation of intraventricular CSF, resulting in progressive ventricular dilation. It can be divided as two groups: hydrocephalus seen in early life and hydrocephalus seen in adults based on the ...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more Application Information
Patent Timeline
Login to view more Patent Type & Authority Applications(United States)
IPC IPC(8): A61M27/00B05D1/18
CPCA61M27/006A61M2207/00A61M2205/0266B05D1/18A61M2205/3344A61M2039/244A61M2039/242
Inventor CHUN, YOUNG JAEEMERY, STEPHEN P.GREENE, STEPHANIESUKINIK, JOSEPH RAFFAEL
Owner UNIV OF PITTSBURGH OF THE COMMONWEALTH SYST OF HIGHER EDUCATION
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Try Eureka
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap